IL1B and depressive symptom measurement: Pathological studies have observed increased expression of TNF-α, IL, IL-1β, IL-6, and C-X3-C modality chemokine receptor 1 (CX3CR1) in the brain of patients with depression (Rahimian et al., 2021).